Fortress Biotech financial statements

포트리스 바이오테크NASDAQ:FBIO · Nasdaq · Healthcare · sector #17
$2.05-1.91%
2026-10-06 close

Fortress Biotech's published financial data is dated 2026-10-04. 2024 revenue was $58M. 2024 operating profit was −$110M.

Reported results

Fortress Biotech notifications

Quantus Signal · live data · not investment advice · Privacy Policy